Y-Intercept (HK)’s Avanos Medical AVNS Stock Holding History

Y-Intercept (HK)’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.21M	Buy	+88,958	New	+$2.08M	0.04%	642
2026 Q1	–	Sell	-40,675	Closed	-$457K	–	1548
2025 Q4	$457K	Buy	40,675 +6,259	+18%	+$71.6K	0.01%	1257
2025 Q3	$398K	Sell	34,416 -45,657	-57%	-$535K	0.01%	1317
2025 Q2	$980K	Buy	80,073 +54,373	+212%	+$684K	0.02%	946
2025 Q1	$368K	Buy	+25,700	New	+$401K	0.03%	835
2024 Q3	–	Sell	-10,436	Closed	-$208K	–	1304
2024 Q2	$208K	Buy	+10,436	New	+$203K	0.01%	1170

Other funds holding AVNS

SRC

Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

SIM

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Y-Intercept (HK)'s AVNS Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Avanos Medical (AVNS) in Q2 2026: 88,958 shares worth $2.21M. The stake represents 0.04% of the portfolio and ranks #642 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in AVNS as recently as Q4 2025.

Y-Intercept (HK) first reported a position in AVNS in Q2 2024 and has held it in 6 quarters since. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Y-Intercept (HK) held 88,958 shares of Avanos Medical worth $2.21M as of Q2 2026.
Avanos Medical was a new Y-Intercept (HK) position in Q2 2026.
Avanos Medical made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #642 holding.
Y-Intercept (HK) first reported a position in Avanos Medical in Q2 2024 and has held it in 6 quarters since.
73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.